Skip to Content

Medican Enterprises Inc MDCN

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Medican Enterprises Inc is a producer and distributor of pharmaceutical grade cannabis to the medical marijuana industry. The company is involved in the business of marketing, research, and development, training, distribution and retail sale of medical and recreational marijuana, both in the United States and Canada. It focuses on cultivating cannabis that includes High tetrahydrocannabinol (THC)/Low Cannabidiol (CBD), Medium THC/Low CBD, Medium THC/Medium CBD and Low TCH/High CBD.

Contact
3440 East Russell Road
Las Vegas, NV, 89120
T +1 800 416-8802
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2015
Fiscal Year End Dec 31, 2015
Stock Type Distressed
Employees 3